Performance Evaluation of the NETTI Wheelchair in Dynamic Mode for Subjects with Involuntary Movements with an Impact on Sitting Position Compared with Its Static Mode. Single-case Experimental Design.

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

This study compares two modes of the NETTI wheelchair (dynamic or sitting) for patients with hyperkinetic syndromes, to discover which mode is the most comfortable and best suited to these patients. It is a prospective, single-center pilot study comparing two medical devices evaluated using SCED (Single Case Experimental Design) ABAB methodology: NETTI DYNAMIC chair in dynamic mode (intervention group; phase B) versus the same chair in static mode (control group; phase A). The subject will be his/her own control

Eligibility
Participation Requirements
Sex: All
Minimum Age: 16
Healthy Volunteers: f
View:

• Patient with involuntary extension movements with a frequency greater than (\>) 3/hour and requiring at least one wheelchair repositioning every 2 hours.

• Patient using a wheelchair and requiring to be in a seated position at least 4 hours per day.

• Patient and/or representative with free and informed consent.

• Patient and/or representative having signed the consent form.

• Patient affiliated or beneficiary of a health insurance plan.

• Patient over 16 years of age (≥16 years).

Locations
Other Locations
France
CHU de Nîmes
RECRUITING
Nîmes
Contact Information
Primary
Arnaud Dupeyron
arnaud.dupeyron@umontpellier.fr
0466683459
Backup
Brigitte LAFONT
brigitte.lafont@chu-nimes.fr
0686384601
Time Frame
Start Date: 2024-03-19
Estimated Completion Date: 2025-08-01
Participants
Target number of participants: 5
Treatments
Control group: STATIC MODE
The patient will be positioned on the Netti Dynamic chair in static mode.
Interventional group: DYNAMIC MODE
The patient will be positioned on the Netti Dynamic chair in dynamic mode.
Sponsors
Leads: Centre Hospitalier Universitaire de Nīmes

This content was sourced from clinicaltrials.gov